…
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; perishable (non-pharma) client packaging; technical services; and advanced monitoring sentry technology. The company was founded in 2006 and is headquartered in Spring Branch, Texas.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public disclosures for Callan JMB Inc. (NASDAQ: CJMB) are limited and the company does not have a clear, widely available description of its core operations in major filings or investor materials. Because long-term growth drivers cannot be identified from public sources, investors may find the company attractive only if it completes a credible acquisition, publishes a detailed strategy, or demonstrates sustainable revenue potential.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Income before tax | -7.97M | -2.27M | 2.20M | 6.30M |
| Net income | -7.97M | -2.29M | 2.18M | 6.22M |
| Selling general administrative | 8.60M | 4.84M | 3.45M | 3.15M |
| Gross profit | 2.10M | 2.56M | 5.65M | 9.45M |
| Reconciled depreciation | 0.15M | 0.14M | 0.10M | 0.07M |
| Ebit | -7.97M | -2.26M | 2.20M | 6.30M |
| Ebitda | -7.81M | -2.12M | 2.30M | 6.37M |
| Depreciation and amortization | 0.15M | 0.14M | 0.10M | 0.07M |
| Operating income | -6.49M | -2.27M | 2.20M | 6.30M |
| Other operating expenses | 12.22M | 8.84M | 11.00M | 16.47M |
| Interest expense | 0.00M | 0.01M | 0.01M | 0.01M |
| Tax provision | -0.00M | 0.03M | 0.02M | 0.07M |
| Interest income | 0.01M | 0.01M | 0.01M | 0.00M |
| Net interest income | 0.01M | 0.01M | 0.00M | -0.01M |
| Income tax expense | -0.00M | 0.03M | 0.02M | 0.07M |
| Total revenue | 5.72M | 6.56M | 13.20M | 22.77M |
| Total operating expenses | 8.60M | 4.84M | 3.45M | 3.15M |
| Cost of revenue | 3.62M | 4.00M | 7.55M | 13.32M |
| Total other income expense net | -1.48M | 0.01M | 0.00M | -0.00M |
| Net income from continuing ops | -7.97M | -2.29M | 2.18M | 6.22M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Total assets | 5.78M | 5.08M | 9.71M | 15.25M |
| Other current assets | 0.34M | 0.41M | 0.28M | 0.25M |
| Total liab | 3.45M | 1.91M | 0.91M | 1.24M |
| Total stockholder equity | 2.33M | 3.17M | 8.80M | 14.01M |
| Other current liab | 0.49M | 0.10M | 0.19M | 0.16M |
| Common stock | 0.00M | 0.00M | 8.80M | 14.01M |
| Capital stock | 0.00M | 0.00M | 0.00M | - |
| Retained earnings | -10.26M | -2.29M | 0.00M | - |
| Cash | 2.13M | 2.10M | 5.16M | 6.19M |
| Total current liabilities | 1.41M | 1.28M | 0.77M | 1.11M |
| Net debt | -0.13M | -1.19M | -4.76M | -5.78M |
| Short term debt | 0.34M | 0.28M | 0.27M | 0.28M |
| Short long term debt | 0.01M | 0.09M | 0.12M | 0.11M |
| Short long term debt total | 2.00M | 0.91M | 0.40M | 0.41M |
| Other stockholder equity | 12.58M | 5.46M | - | - |
| Total current assets | 3.06M | 3.32M | 8.45M | 14.37M |
| Net receivables | 0.34M | 0.65M | 2.90M | 7.85M |
| Inventory | 0.24M | 0.16M | 0.11M | 0.08M |
| Accounts payable | 0.56M | 0.88M | 0.31M | 0.67M |
| Accumulated other comprehensive income | - | 0.00M | - | - |
| Non currrent assets other | - | 0.00M | 0.00M | 0.00M |
| Non current assets total | 2.72M | 1.76M | 1.25M | 0.88M |
| Capital lease obligations | 1.99M | 0.91M | 0.28M | 0.30M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
| Investments | - | -0.05M | -0.49M | -0.42M |
| Total cashflows from investing activities | -0.62M | -0.05M | -0.49M | -0.42M |
| Net borrowings | 0.02M | -0.12M | -0.12M | -0.17M |
| Total cash from financing activities | 5.20M | -3.55M | -7.54M | -4.57M |
| Net income | -7.97M | -2.29M | 2.18M | 6.22M |
| Change in cash | 0.03M | -3.06M | -1.04M | 4.37M |
| Begin period cash flow | 2.10M | 5.16M | 6.19M | 1.82M |
| End period cash flow | 2.13M | 2.10M | 5.16M | 6.19M |
| Total cash from operating activities | -4.55M | 0.54M | 7.00M | 9.36M |
| Issuance of capital stock | 5.04M | 0.00M | - | - |
| Depreciation | 0.15M | 0.14M | 0.10M | 0.07M |
| Other cashflows from investing activities | -0.62M | - | - | - |
| Dividends paid | 0.00M | 3.33M | 7.40M | 4.45M |
| Change to inventory | -0.08M | -0.04M | -0.04M | 0.06M |
| Change to account receivables | 0.06M | 2.41M | 4.67M | 6.88M |
| Other cashflows from financing activities | 0.14M | -0.11M | -0.15M | 0.05M |
| Capital expenditures | 0.62M | 0.05M | 0.49M | 0.42M |
| Change in working capital | 0.04M | 2.34M | 4.75M | 2.97M |
| Stock based compensation | 1.56M | 0.00M | - | - |
| Other non cash items | 3.37M | 0.35M | -0.04M | 0.10M |
| Free cash flow | -5.16M | 0.49M | 6.51M | 8.94M |
Sector: Industrials Industry: Integrated Freight & Logistics
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
|---|---|---|---|---|---|---|---|
| CJMB Callan JMB Inc. Common Stock |
-0.01 1.86% |
0.34 | - | - | 1.14 | 2.80 | 1.12 |
| FDX FedEx Corporation |
-0.23 0.07% |
318.02 | 21.06 | 17.86 | 1.02 | 3.16 | 1.39 |
| UPS United Parcel Service Inc |
-0.54 0.49% |
109.17 | 19.06 | 12.89 | 0.97 | 5.79 | 1.24 |
| DHLGY Deutsche Post AG |
-0.19 0.58% |
32.84 | 16.10 | 15.72 | 0.78 | 2.52 | 0.95 |
| DSDVY DSV Panalpina A/S ADR |
-0.01 0.01% |
108.28 | 48.35 | 24.63 | 0.26 | 3.46 | 1.99 |
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, which includes managing their building sites, medical stockpiles of equipment, and supplies and responding to state or local emergencies; perishable (non-pharma) client packaging; technical services; and advanced monitoring sentry technology. The company was founded in 2006 and is headquartered in Spring Branch, Texas.
244 Flightline Drive, Spring Branch, TX, United States, 78070-6241
830 438 0395
18
| Name | Title | Year Born |
|---|---|---|
| Mr. Wayne Williams | Founder, CEO, President & Chairman | 1964 |
| Mr. Christopher Shields | Interim CFO & Senior VP of Governmental Affairs and COO | 1969 |
| Mr. Eric L. Kash | Executive VP & Director | 1958 |
| Dr. David J. Croyle M.D. | Chief Medical Officer | 1959 |
| Mr. Wiliam McBride | Chief Information Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.